70% Remission for Postpartum Depression? The Psychedelic Breakthrough episode artwork

EPISODE · Apr 30, 2026 · 35 MIN

70% Remission for Postpartum Depression? The Psychedelic Breakthrough

from Power to the Patients · host Brandon Li

Postpartum depression treatment advances with psychedelic therapy. Greg Mayes of Reunion Neuroscience discusses luvesilocin drug development. This episode explores how shorter-acting psilocybin analogs offer new hope for mothers. Greg highlights the success of the RECONNECT study and the path to FDA breakthrough designation.

Postpartum depression treatment advances with psychedelic therapy. Greg Mayes of Reunion Neuroscience discusses luvesilocin drug development. This episode explores how shorter-acting psilocybin analogs offer new hope for mothers. Greg highlights the success of the RECONNECT study and the path to FDA breakthrough designation.

NOW PLAYING

70% Remission for Postpartum Depression? The Psychedelic Breakthrough

0:00 35:54

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Power to the Patients?

This episode is 35 minutes long.

When was this Power to the Patients episode published?

This episode was published on April 30, 2026.

What is this episode about?

Postpartum depression treatment advances with psychedelic therapy. Greg Mayes of Reunion Neuroscience discusses luvesilocin drug development. This episode explores how shorter-acting psilocybin analogs offer new hope for mothers. Greg highlights the...

Can I download this Power to the Patients episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!